This document contains balance sheet forecasts for GlaxoSmithKline from FY14A to FY20E, detailing tangible fixed assets, goodwill, other intangibles, and various liabilities and equity figures. The data is sourced from Deutsche Bank estimates and company details.
documents/vol00010-efta01457564-pdf.pdf
{"title":"Balance Sheet Forecasts","document_date":"2016-05-11","document_type":"tabular","key_locations":["London"],"key_organizations":["GlaxoSmithKline","Deutsche Bank AG"]}